BDNF signaling via the tropomyosin-related kinase B (Trk-B) receptor promotes trafficking of AMPA receptors to glioma cell membranes, thereby modulating the amplitude of postsynaptic currents (28). Here, BDNF is linked to central nervous system cancer.